Journal
JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 15, Pages -Publisher
MDPI
DOI: 10.3390/jcm11154311
Keywords
data mining; familial chylomicronemia syndrome; FCS score; machine learning; screening
Categories
Funding
- Bridging Fund (Faculty of Medicine, University of Debrecen) [GINOP-2.3.2-15-2016-00005]
- European Union under the European Regional Development Fund
- MIS Learning from Pairwise Comparisons of the F.R.S.-FNRS
- MTA Premium Postdoctoral Grant
Ask authors/readers for more resources
This study aimed to assess the prevalence of familial chylomicronemia syndrome (FCS) in Central Europe and evaluate the diagnostic applicability of the FCS score. Through the analysis of medical records and machine learning models, it was found that FCS has a higher prevalence in the region, and additional features can improve the accuracy of the FCS score calculation.
Background: There are no exact data about the prevalence of familial chylomicronemia syndrome (FCS) in Central Europe. We aimed to identify FCS patients using either the FCS score proposed by Moulin et al. or with data mining, and assessed the diagnostic applicability of the FCS score. Methods: Analyzing medical records of 1,342,124 patients, the FCS score of each patient was calculated. Based on the data of previously diagnosed FCS patients, we trained machine learning models to identify other features that may improve FCS score calculation. Results: We identified 26 patients with an FCS score of >= 10. From the trained models, boosting tree models and support vector machines performed the best for patient recognition with overall AUC above 0.95, while artificial neural networks accomplished above 0.8, indicating less efficacy. We identified laboratory features that can be considered as additions to the FCS score calculation. Conclusions: The estimated prevalence of FCS was 19.4 per million in our region, which exceeds the prevalence data of other European countries. Analysis of larger regional and country-wide data might increase the number of FCS cases. Although FCS score is an excellent tool in identifying potential FCS patients, consideration of some other features may improve its accuracy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available